8,686
Total Claims
$1.9M
Drug Cost
1,047
Beneficiaries
$1,820
Cost/Patient
Peer Comparison vs. 18,720 Cardiology providers
+19%
Cost per patient vs peers
$1,820 vs $1,524 avg
+31%
Brand preference vs peers
17.9% vs 13.7% avg
Brand vs Generic
82% generic
Brand: 1,551 claims · $1.7M
Generic: 7,135 claims · $158K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 796 | $946K |
| Sacubitril/Valsartan | 246 | $288K |
| Evolocumab | 132 | $157K |
| Empagliflozin | 128 | $149K |
| Rivaroxaban | 75 | $88K |
| Alirocumab | 53 | $54K |
| Dapagliflozin Propanediol | 17 | $26K |
| Ezetimibe | 373 | $16K |
| Eplerenone | 79 | $13K |
| Rosuvastatin Calcium | 633 | $12K |
| Metoprolol Succinate | 627 | $11K |
| Nebivolol Hcl | 119 | $9,504 |
| Atorvastatin Calcium | 626 | $8,293 |
| Diltiazem Hcl | 172 | $7,108 |
| Bumetanide | 174 | $7,053 |
Prescribing Profile
54
Unique Drugs
$1.5M
Patient Profile
75
Avg Age
51%
Female
1.51
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data